Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts

[1]         A. M. Kligman, "Pathologic dynamics of human hair loss: I. Telogen effluvium," Archives of dermatology, vol. 83, pp. 175-198, 1961.

[2]         S. Malkud, "A hospital-based study to determine causes of diffuse hair loss in women," Journal of clinical and diagnostic research: JCDR, vol. 9, pp. WC01, 2015.

[3]         S. Harrison and R. Sinclair, "Telogen effluvium," Clinical and experimental dermatology, vol. 27, pp. 389-395, 2002.

[4]         C. Grover and A. Khurana, "Telogen effluvium," Indian journal of dermatology, venereology and leprology, vol. 79, pp. 591, 2013.

[5]         C. Pierard-Franchimont and G. Pierard, "Teloptosis, a turning point in hair shedding biorhythms," Dermatology, vol. 203, pp. 115-117, 2001.

[6]         W.-Y. Huang, Y.-C. Huang, K.-S. Huang, C.-C. Chan, H.-Y. Chiu, R.-Y. Tsai, et al., "Stress-induced premature senescence of dermal papilla cells compromises hair follicle epithelial-mesenchymal interaction," Journal of dermatological science, vol. 86, pp. 114-122, 2017.

[7]         A. Rebora, "Telogen effluvium: a comprehensive review," Clinical, cosmetic and investigational dermatology, vol. 12, pp. 583-590, 2019.

[8]         M. Fukuyama, T. Ito, and M. Ohyama, "Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines," The Journal of dermatology, vol. 49, pp. 19-36, 2022.

[9]         M. Kinoshita-Ise, M. Fukuyama, and M. Ohyama, "Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases," Journal of Clinical Medicine, vol. 12, pp. 3259, 2023.

[10]       G. O. C. Yin, J. L. Siong-See, and E. C. Wang, "Telogen Effluvium–a review of the science and current obstacles," Journal of Dermatological Science, vol. 101, pp. 156-163, 2021.

[11]       J. T. Headington, "Telogen effluvium: new concepts and review," Archives of dermatology, vol. 129, pp. 356-363, 1993.

[12]       D. A. Whiting, "Chronic telogen effluvium: increased scalp hair shedding in middle-aged women," Journal of the American Academy of Dermatology, vol. 35, pp. 899-906, 1996.

[13]       A. Tosti and M. Pazzaglia, "Drug reactions affecting hair: diagnosis," Dermatologic clinics, vol. 25, pp. 223-231, 2007.

[14]       M. Kinoshita‐Ise and M. Sachdeva, "Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart," The Journal of Dermatology, vol. 49, pp. 4-18, 2022.

[15]       K. A. McDonald, A. J. Shelley, K. Maliyar, T. Abdalla, R. A. Beach, and J. Beecker, "Hair pull test: A clinical update for patients with Asian-and Afro-textured hair," Journal of the American Academy of Dermatology, vol. 85, pp. 1599-1601, 2021.

[16]       K. A. McDonald, A. J. Shelley, S. Colantonio, and J. Beecker, "Hair pull test: Evidence-based update and revision of guidelines," Journal of the American Academy of Dermatology, vol. 76, pp. 472-477, 2017.

[17]       M. Kinoshita-Ise, M. Ohyama, J. M. Ramjist, F. S. Foster, V. X. Yang, M. Sachdeva, et al., "Ultra high-frequency ultrasound with seventy-MHz transducer in hair disorders: Development of a novel noninvasive diagnostic methodology," Journal of Dermatological Science, vol. 102, pp. 167-176, 2021.

[18]       A. Rajabi‐Estarabadi, N. Vasquez‐Herrera, M. Martinez‐Velasco, J. Tsatalis, S. Verne, K. Nouri, et al., "Optical coherence tomography in diagnosis of inflammatory scalp disorders," Journal of the European Academy of Dermatology and Venereology, vol. 34, pp. 2147-2151, 2020.

[19]       T. A. Turkan and J. R. Al-Rawi, "Vitamin D level and telogen hair loss: A Case control study," Journal of the Faculty of Medicine Baghdad, vol. 63, 2021.

[20]       R. E. MAJEED, S. F. SALIH, and A. S. MOHAMMED, "SERUM VITAMIN D3 LEVELS IN PATIENTS WITH TELOGEN EFFLUVIUM IN DUHOK GOVERNORATE," Duhok Medical Journal, vol. 17, pp. 39-50, 2023.

[21]       F. El-esrigy, A. H Maraee, and H. M Elsayed, "Telogen Effluvium: Prevalence Associated Factors with Reference to Iron Deficiency Anemia Among Childbearing Women, Gharbia Governorate, Egypt," The Egyptian Family Medicine Journal, vol. 2, pp. 1-12, 2018.

[22]       S.-H. Loh, B.-L. Lew, and W.-Y. Sim, "Localized telogen effluvium following hair transplantation," Annals of Dermatology, vol. 30, pp. 214-217, 2018.

[23]       L. Alhanshali, F. Bawany, M. G. Buontempo, J. Shapiro, and K. L. Sicco, "Understanding perceptions of hair loss in hijab-wearing women: a pilot survey study," International Journal of Women's Dermatology, vol. 9, pp. e115, 2023.

[24]       L. Alhanshali, M. G. Buontempo, F. Bawany, P. Adotama, J. Shapiro, and K. L. Sicco, "Religious headwear and alopecia: considerations for dermatologists,"  vol. 9, ed: LWW, pp. e107, 2023.

[25]       M. S. Ceresnie, L. Mohney, L. Seale, F. Fahs, and T. F. Mohammad, "The development of non-scarring alopecia in women who wear the hijab," vol. 315(10), pp. 2947-2949, 2023.

[26]       J. Gherardini, J. Wegner, J. Chéret, S. Ghatak, J. Lehmann, M. Alam, et al., "Transepidermal UV radiation of scalp skin ex vivo induces hair follicle damage that is alleviated by the topical treatment with caffeine," International journal of cosmetic science, vol. 41, pp. 164-182, 2019.

[27]       K. E. Sharquie and R. I. Jabbar, "COVID-19 infection is a major cause of acute telogen effluvium," Irish Journal of Medical Science (1971-), vol. 191, pp. 1677-1681, 2022.

[28]       G. M. Iancu, E. Molnar, L. Ungureanu, S. C. Șenilă, A. Hașegan, and M. Rotaru, "SARS-CoV-2 infection—a trigger factor for telogen effluvium: review of the literature with a case-based guidance for clinical evaluation," Life, vol. 13, pp. 1576, 2023.

[29]       K. Mieczkowska, A. Deutsch, J. Borok, A. K. Guzman, R. Fruchter, P. Patel, et al., "Telogen effluvium: a sequela of COVID‐19," International journal of dermatology, vol. 60, pp. 122, 2021.

[30]       P. Gentile, "Hair loss and telogen effluvium related to COVID-19: The potential implication of adipose-derived mesenchymal stem cells and platelet-rich plasma as regenerative strategies," International Journal of Molecular Sciences, vol. 23, pp. 9116, 2022.

[31]       A. C. Inamadar, "Covid induced telogen effluvium (CITE): An insight," Indian Dermatology Online Journal, vol. 13, pp. 445, 2022.

[32]       J. Garg, A. Cline, and F. Pereira, "Increase in Google Trends Regarding Telogen Effluvium Due To COVID-19," SKIN The Journal of Cutaneous Medicine, vol. 5, pp. 137-139, 2021.

[33]       R. Dawber and B. L. Connor, "Pregnancy, hair loss, and the pill," British Medical Journal, vol. 4, pp. 234, 1971.

[34]       R. Strumia, "Dermatologic signs in patients with eating disorders," American journal of clinical dermatology, vol. 6, pp. 165-173, 2005.

[35]       M. Cutrone and R. Grimalt, "Transient neonatal hair loss: a common transient neonatal dermatosis," European journal of pediatrics, vol. 164, pp. 630-632, 2005.

[36]       S. Gilmore and R. Sinclair, "Chronic telogen effluvium is due to a reduction in the variance of anagen duration," Australasian journal of dermatology, vol. 51, pp. 163-167, 2010.

[37]       F. Asghar, N. Shamim, U. Farooque, H. Sheikh, and R. Aqeel, "Telogen effluvium: a review of the literature," Cureus, vol. 12(5), pp. e8320, 2020.

[38]       A. J. Jackson and V. H. Price, "How to diagnose hair loss," Dermatologic clinics, vol. 31, pp. 21-28, 2013.

[39]       E. N. Nnoruka, I. Obiagboso, and C. Maduechesi, "Hair loss in children in South‐East Nigeria: common and uncommon cases," International journal of dermatology, vol. 46, pp. 18-22, 2007.

[40]       İ. Kivanç‐Altunay, C. Savaş, G. Gökdemir, A. Köşlü, and E. B. Ayaydin, "The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia," International journal of dermatology, vol. 42, pp. 691-693, 2003.

[41]       A. Rebora, "Trichodynia: a review of the literature," International Journal of Dermatology, vol. 55, pp. 382-384, 2016.

[42]       R. M. Trüeb, M. V. Starace, B. M. Piraccini, H. D. Rezende, and M. F. R. G. Dias, "Trichodynia Revisited," Skin Appendage Disorders, vol. 7, pp. 449, 2021.

[43]       E. Ludwig, "Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex," British Journal of Dermatology, vol. 97, pp. 247-254, 1977.

[44]       H. Aksoy, U. M. Yıldırım, P. Ergen, and M. S. Gürel, "COVID‐19 induced telogen effluvium," Dermatologic therapy, vol. 34, pp. e15175, 2021.

[45]       J. Shapiro, "Hair loss in women," New England Journal of Medicine, vol. 357, pp. 1620-1630, 2007.

[46]       R. Dhurat, "Phototrichogram," Indian journal of dermatology, venereology and leprology, vol. 72, pp. 242, 2006.

[47]       M. Miteva and A. Tosti, "Dermatoscopy of hair shaft disorders," Journal of the American Academy of Dermatology, vol. 68, pp. 473-481, 2013.

[48]       A. Rakowska, M. Slowinska, E. Kowalska-Oledzka, M. Olszewska, and L. Rudnicka, "Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria," International journal of trichology, vol. 1, pp. 123, 2009.

[49]       M. Guarrera, M. C. Fiorucci, and A. Rebora, "Methods of hair loss evaluation: a comparison of T richo S can® with the modified wash test," Experimental Dermatology, vol. 22, pp. 482-484, 2013.

[50]       H. B. Fathi, M. N. Abdulqader, and O. Y. Abdullah, "Hair Fall Count 60-second: Clinic-Based Modified Count Versus Home-Based Count," Al-Anbar Medical Journal, vol. 19(2), pp. 123–127, 2023.

[51]       A. Chong, M. Wade, and R. Sinclair, "The hair pull test and the hair pluck for analysis of hair abnormalities," Modern Medicine of Australia, vol. 42, pp. 105-110, 1999.

[52]       R. Hoffmann, "TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo," European Journal of Dermatology, vol. 11, pp. 362-8, 2001.

[53]       M. LALU, N. MANICKAM, K. GOPALAN, and S. G. VELLAISAMY, "Impact on Quality of Life among Females with Diffuse Hair Loss at a Tertiary Care Centre: A Cross-sectional Study," Journal of Clinical & Diagnostic Research, vol. 15(10), 2021.

[54]       N. Wei, E. Elbogen, J. Dan, A. Chessky, R. Rivera-Oyola, and M. Lebwohl, "Telogen Effluvium in Patients recovering from COVID-19," SKIN The Journal of Cutaneous Medicine, vol. 5, pp. 533-537, 2021.

[55]       A. Esfandiari and A. P. Kelly, "The effects of tea polyphenolic compounds on hair loss among rodents," Journal of the National Medical Association, vol. 97, pp. 1165, 2005.

[56]       E. Perera and R. Sinclair, "Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study," F1000Research, vol. 6:6, pp. 1650, 2017.

[57]       V. Mysore, A. Parthasaradhi, R. Kharkar, A. Ghoshal, A. Ganjoo, G. Ravichandran, et al., "Expert consensus on the management of Telogen Effluvium in India," International journal of trichology, vol. 11, pp. 107, 2019.

[58]       A. Rebora, "Telogen effluvium," Dermatology, vol. 195, pp. 209-212, 1997.

[59]       M. Davis, J. Thomas, S. Van de Velde, Y. Boissy, T. Dawson Jr, R. Iveson, et al., "A novel cosmetic approach to treat thinning hair," British Journal of Dermatology, vol. 165, pp. 24-30, 2011.

[60]       M. G. Davis, M. P. Piliang, W. F. Bergfeld, T. L. Caterino, B. K. Fisher, J. P. Sacha, et al., "Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24‐week randomized, double‐blind, placebo‐controlled clinical trial," International Journal of Cosmetic Science, vol. 43, pp. S14-S25, 2021.

[61]       S. Zari, "Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium," Stem Cells and Cloning: Advances and Applications, vol. 20:16, pp. 77-89, 2023.

[62]       S. Garg and S. Manchanda, "Platelet-rich plasma—an ‘Elixir’for treatment of alopecia: personal experience on 117 patients with review of literature," Stem cell investigation, vol. 4:64, 2017.

[63]       R. E. El-Dawla, M. Abdelhaleem, and A. Abdelhamed, "Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial," Indian Journal of Dermatology, Venereology and Leprology, vol. 89, pp. 196, 2023.

[64]       R. Alves and R. Grimalt, "Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia," Dermatologic surgery, vol. 42, pp. 491-497, 2016.

[65]       Z. J. Li, H.-I. Choi, D.-K. Choi, K.-C. Sohn, M. Im, Y.-J. Seo, et al., "Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth," Dermatologic Surgery, vol. 38, pp. 1040-1046, 2012.

[66]       G. Maria-Angeliki, K. Alexandros-Efstratios, R. Dimitris, and K. Konstantinos, "Platelet-rich plasma as a potential treatment for noncicatricial alopecias," International journal of trichology, vol. 7, pp. 54, 2015.

[67]       M.-J. García-Hernández and F. M. Camacho, "Chronic telogen effluvium: incidence, clinical and biochemical features, and treatment," Archives of dermatology, vol. 135, pp. 1123-1124, 1999.